Pacific Biosciences of California Inc at UBS Genomics 2.0 and MedTech Innovations Summit Transcript
Welcome to the last fireside here on day 2 of the 2023 UBS conference. I'm John Sourbeer, one of the UBS Life Science's analyst. Joining me on stage is Liza Garcia, my co-coverage. Last but not least, we're really happy to be hosting PacBio here, fireside chat. Joining today is COO, Mark Van Oene; and Senior Director of Investor Relations, Todd Friedman.
Thanks both for joining us here.
Great. Thanks for having us John and thanks for hosting the stuck around.
Questions & Answers
Maybe we started Revio, lots of talks in demand here in the market, but the long replatform has launched us here. So year-to-date placements have been strong, beat consensus last 2 quarters. Can you just talk about where you're seeing customer demand for these placements? What are new to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
